Celularity Inc.
CELU
$2.04
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 44.59M | 50.97M | 54.22M | 48.20M | 42.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.59M | 50.97M | 54.22M | 48.20M | 42.69M |
| Cost of Revenue | 20.02M | 16.90M | 14.99M | 17.26M | 16.97M |
| Gross Profit | 24.57M | 34.06M | 39.23M | 30.95M | 25.72M |
| SG&A Expenses | 55.60M | 58.88M | 58.64M | 55.65M | 53.75M |
| Depreciation & Amortization | 1.49M | 1.58M | 1.75M | 1.93M | 2.11M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 91.94M | 92.63M | 92.77M | 88.12M | 87.39M |
| Operating Income | -47.35M | -41.66M | -38.55M | -39.92M | -44.70M |
| Income Before Tax | -73.67M | -55.63M | -57.89M | -35.04M | -112.82M |
| Income Tax Expenses | -- | -- | -- | 10.00K | 10.00K |
| Earnings from Continuing Operations | -73.67 | -55.63 | -57.89 | -35.05 | -112.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.67M | -55.63M | -57.89M | -35.05M | -112.83M |
| EBIT | -47.35M | -41.66M | -38.55M | -39.92M | -44.70M |
| EBITDA | -39.91M | -34.06M | -30.63M | -31.58M | -35.91M |
| EPS Basic | -3.19 | -2.47 | -2.65 | -1.56 | -5.81 |
| Normalized Basic EPS | -1.80 | -1.38 | -1.54 | -0.82 | -0.73 |
| EPS Diluted | -3.19 | -2.47 | -2.65 | -1.56 | -5.81 |
| Normalized Diluted EPS | -1.80 | -1.38 | -1.54 | -0.82 | -0.73 |
| Average Basic Shares Outstanding | 91.82M | 89.65M | 87.56M | 84.46M | 81.31M |
| Average Diluted Shares Outstanding | 91.82M | 89.65M | 87.56M | 84.46M | 81.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |